Loading…
Prostate cancer in older men : Special features of the diagnostics and treatment
Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic disease, androgen deprivation treatment is carried out. Further options include inhibi...
Saved in:
Published in: | Zeitschrift für Gerontologie und Geriatrie 2023-07, Vol.56 (4), p.324 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | ger |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 4 |
container_start_page | 324 |
container_title | Zeitschrift für Gerontologie und Geriatrie |
container_volume | 56 |
creator | Degener, Stephan Schmalz, Oliver Tosch, Marco Gödde, Daniel von Rundstedt, Friedrich-Carl Piroth, Marc D |
description | Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic disease, androgen deprivation treatment is carried out. Further options include inhibitors of the androgen receptor axis and taxane-based chemotherapy. The avoidance of side effects should be considered, e.g., by dose adjustment. New options include poly(ADP-ribose) polymerase (PARP) inhibitors, and radioligand treatment. The existing guidelines only provide a few treatment recommendations for older patients; however, the treatment of older patients should primarily consider not only chronological age but also the patient's psychological and physical condition and preferences. In this context, the geriatric assessment represents an important instrument for determining the treatment strategy. |
doi_str_mv | 10.1007/s00391-023-02194-z |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37306771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37306771</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-868f1526c20765b7db3219363b3c6dbe34803950fdd046406985fe6d0552f4633</originalsourceid><addsrcrecordid>eNo1T81KxDAYDIK46-oLeJC8QPRLv-RL600W_2DBBfW8pPnRStstTfagT29APQwzh5lhhrELCVcSwFwnAGykgAoLZKPE9xFbSoVayIqaBTtN6RNAGkPyhC3QIJAxcsm223mfss2BOzu6MPNu5PveFzGEkd_wlym4zvY8BpsPc0h8H3n-CNx39n0syc4lbkfP81wMJZLP2HG0fQrnf7xib_d3r-tHsXl-eFrfbsQkoc6ipjpKXZGrwJBujW-xzEbCFh35NqCqyyEN0XtQpICaWsdAHrSuoiLEFbv87Z0O7RD8bpq7wc5fu_9r-APy-04T</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prostate cancer in older men : Special features of the diagnostics and treatment</title><source>Springer Nature</source><creator>Degener, Stephan ; Schmalz, Oliver ; Tosch, Marco ; Gödde, Daniel ; von Rundstedt, Friedrich-Carl ; Piroth, Marc D</creator><creatorcontrib>Degener, Stephan ; Schmalz, Oliver ; Tosch, Marco ; Gödde, Daniel ; von Rundstedt, Friedrich-Carl ; Piroth, Marc D</creatorcontrib><description>Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic disease, androgen deprivation treatment is carried out. Further options include inhibitors of the androgen receptor axis and taxane-based chemotherapy. The avoidance of side effects should be considered, e.g., by dose adjustment. New options include poly(ADP-ribose) polymerase (PARP) inhibitors, and radioligand treatment. The existing guidelines only provide a few treatment recommendations for older patients; however, the treatment of older patients should primarily consider not only chronological age but also the patient's psychological and physical condition and preferences. In this context, the geriatric assessment represents an important instrument for determining the treatment strategy.</description><identifier>EISSN: 1435-1269</identifier><identifier>DOI: 10.1007/s00391-023-02194-z</identifier><identifier>PMID: 37306771</identifier><language>ger</language><publisher>Germany</publisher><ispartof>Zeitschrift für Gerontologie und Geriatrie, 2023-07, Vol.56 (4), p.324</ispartof><rights>2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37306771$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Degener, Stephan</creatorcontrib><creatorcontrib>Schmalz, Oliver</creatorcontrib><creatorcontrib>Tosch, Marco</creatorcontrib><creatorcontrib>Gödde, Daniel</creatorcontrib><creatorcontrib>von Rundstedt, Friedrich-Carl</creatorcontrib><creatorcontrib>Piroth, Marc D</creatorcontrib><title>Prostate cancer in older men : Special features of the diagnostics and treatment</title><title>Zeitschrift für Gerontologie und Geriatrie</title><addtitle>Z Gerontol Geriatr</addtitle><description>Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic disease, androgen deprivation treatment is carried out. Further options include inhibitors of the androgen receptor axis and taxane-based chemotherapy. The avoidance of side effects should be considered, e.g., by dose adjustment. New options include poly(ADP-ribose) polymerase (PARP) inhibitors, and radioligand treatment. The existing guidelines only provide a few treatment recommendations for older patients; however, the treatment of older patients should primarily consider not only chronological age but also the patient's psychological and physical condition and preferences. In this context, the geriatric assessment represents an important instrument for determining the treatment strategy.</description><issn>1435-1269</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo1T81KxDAYDIK46-oLeJC8QPRLv-RL600W_2DBBfW8pPnRStstTfagT29APQwzh5lhhrELCVcSwFwnAGykgAoLZKPE9xFbSoVayIqaBTtN6RNAGkPyhC3QIJAxcsm223mfss2BOzu6MPNu5PveFzGEkd_wlym4zvY8BpsPc0h8H3n-CNx39n0syc4lbkfP81wMJZLP2HG0fQrnf7xib_d3r-tHsXl-eFrfbsQkoc6ipjpKXZGrwJBujW-xzEbCFh35NqCqyyEN0XtQpICaWsdAHrSuoiLEFbv87Z0O7RD8bpq7wc5fu_9r-APy-04T</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Degener, Stephan</creator><creator>Schmalz, Oliver</creator><creator>Tosch, Marco</creator><creator>Gödde, Daniel</creator><creator>von Rundstedt, Friedrich-Carl</creator><creator>Piroth, Marc D</creator><scope>NPM</scope></search><sort><creationdate>202307</creationdate><title>Prostate cancer in older men : Special features of the diagnostics and treatment</title><author>Degener, Stephan ; Schmalz, Oliver ; Tosch, Marco ; Gödde, Daniel ; von Rundstedt, Friedrich-Carl ; Piroth, Marc D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-868f1526c20765b7db3219363b3c6dbe34803950fdd046406985fe6d0552f4633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Degener, Stephan</creatorcontrib><creatorcontrib>Schmalz, Oliver</creatorcontrib><creatorcontrib>Tosch, Marco</creatorcontrib><creatorcontrib>Gödde, Daniel</creatorcontrib><creatorcontrib>von Rundstedt, Friedrich-Carl</creatorcontrib><creatorcontrib>Piroth, Marc D</creatorcontrib><collection>PubMed</collection><jtitle>Zeitschrift für Gerontologie und Geriatrie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Degener, Stephan</au><au>Schmalz, Oliver</au><au>Tosch, Marco</au><au>Gödde, Daniel</au><au>von Rundstedt, Friedrich-Carl</au><au>Piroth, Marc D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate cancer in older men : Special features of the diagnostics and treatment</atitle><jtitle>Zeitschrift für Gerontologie und Geriatrie</jtitle><addtitle>Z Gerontol Geriatr</addtitle><date>2023-07</date><risdate>2023</risdate><volume>56</volume><issue>4</issue><spage>324</spage><pages>324-</pages><eissn>1435-1269</eissn><abstract>Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic disease, androgen deprivation treatment is carried out. Further options include inhibitors of the androgen receptor axis and taxane-based chemotherapy. The avoidance of side effects should be considered, e.g., by dose adjustment. New options include poly(ADP-ribose) polymerase (PARP) inhibitors, and radioligand treatment. The existing guidelines only provide a few treatment recommendations for older patients; however, the treatment of older patients should primarily consider not only chronological age but also the patient's psychological and physical condition and preferences. In this context, the geriatric assessment represents an important instrument for determining the treatment strategy.</abstract><cop>Germany</cop><pmid>37306771</pmid><doi>10.1007/s00391-023-02194-z</doi></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1435-1269 |
ispartof | Zeitschrift für Gerontologie und Geriatrie, 2023-07, Vol.56 (4), p.324 |
issn | 1435-1269 |
language | ger |
recordid | cdi_pubmed_primary_37306771 |
source | Springer Nature |
title | Prostate cancer in older men : Special features of the diagnostics and treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A03%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate%20cancer%20in%20older%20men%20:%20Special%20features%20of%20the%20diagnostics%20and%20treatment&rft.jtitle=Zeitschrift%20f%C3%BCr%20Gerontologie%20und%20Geriatrie&rft.au=Degener,%20Stephan&rft.date=2023-07&rft.volume=56&rft.issue=4&rft.spage=324&rft.pages=324-&rft.eissn=1435-1269&rft_id=info:doi/10.1007/s00391-023-02194-z&rft_dat=%3Cpubmed%3E37306771%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-868f1526c20765b7db3219363b3c6dbe34803950fdd046406985fe6d0552f4633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/37306771&rfr_iscdi=true |